Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)
CNY 15.77
(0.9%)
CNY 15.77
(0.9%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 464.12 Million CNY | -8.71% |
| 2022 | 508.41 Million CNY | 11.11% |
| 2021 | 457.56 Million CNY | 50.24% |
| 2020 | 304.55 Million CNY | 85.83% |
| 2019 | 163.88 Million CNY | 153.41% |
| 2018 | 64.67 Million CNY | 453.34% |
| 2017 | 11.68 Million CNY | 7185.79% |
| 2016 | 160.41 Thousand CNY | -61.49% |
| 2015 | 416.51 Thousand CNY | 403.34% |
| 2014 | 82.75 Thousand CNY | -83.26% |
| 2013 | 494.36 Thousand CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 142.78 Million CNY | 118.19% |
| 2024 Q1 | 65.44 Million CNY | -52.2% |
| 2024 Q3 | 151.62 Million CNY | 6.19% |
| 2023 Q4 | 136.89 Million CNY | 24.17% |
| 2023 Q3 | 110.24 Million CNY | -29.9% |
| 2023 FY | 464.12 Million CNY | -8.71% |
| 2023 Q1 | 59.71 Million CNY | -63.77% |
| 2023 Q2 | 157.26 Million CNY | 163.35% |
| 2022 Q2 | 164.61 Million CNY | 225.12% |
| 2022 Q1 | 50.63 Million CNY | -73.91% |
| 2022 FY | 508.41 Million CNY | 11.11% |
| 2022 Q4 | 164.83 Million CNY | 28.44% |
| 2022 Q3 | 128.33 Million CNY | -22.04% |
| 2021 Q2 | 95.88 Million CNY | 57.38% |
| 2021 Q4 | 194.04 Million CNY | 81.83% |
| 2021 Q1 | 60.92 Million CNY | -41.68% |
| 2021 FY | 457.56 Million CNY | 50.24% |
| 2021 Q3 | 106.71 Million CNY | 11.3% |
| 2020 Q2 | 75.89 Million CNY | 176.73% |
| 2020 FY | 304.55 Million CNY | 85.83% |
| 2020 Q3 | 95.34 Million CNY | 25.62% |
| 2020 Q4 | 104.46 Million CNY | 9.57% |
| 2020 Q1 | 27.42 Million CNY | -49.0% |
| 2019 Q1 | 9.4 Million CNY | 0.0% |
| 2019 FY | 163.88 Million CNY | 153.41% |
| 2019 Q4 | 53.77 Million CNY | 0.0% |
| 2018 Q1 | 10.78 Million CNY | -37.89% |
| 2018 Q2 | 10.78 Million CNY | 0.0% |
| 2018 FY | 64.67 Million CNY | 453.34% |
| 2017 Q4 | 17.36 Million CNY | 0.0% |
| 2017 FY | 11.68 Million CNY | 7185.79% |
| 2017 Q1 | 2.78 Million CNY | 3518.86% |
| 2017 Q3 | 17.36 Million CNY | 522.84% |
| 2017 Q2 | 2.78 Million CNY | 0.0% |
| 2016 Q1 | 3170.00 CNY | -95.0% |
| 2016 Q4 | 77.03 Thousand CNY | 0.0% |
| 2016 FY | 160.41 Thousand CNY | -61.49% |
| 2016 Q3 | 77.03 Thousand CNY | 2331.02% |
| 2016 Q2 | 3169.00 CNY | -0.03% |
| 2015 Q3 | 63.38 Thousand CNY | -56.25% |
| 2015 Q2 | 144.87 Thousand CNY | 0.0% |
| 2015 Q1 | 144.87 Thousand CNY | 0.0% |
| 2015 FY | 416.51 Thousand CNY | 403.34% |
| 2015 Q4 | 63.38 Thousand CNY | 0.0% |
| 2014 FY | 82.75 Thousand CNY | -83.26% |
| 2013 FY | 494.36 Thousand CNY | 0.0% |